Supplemental material
Journal of Enzyme Inhibition and Medicinal Chemistry
Volume 33, 2018 - Issue 1
Related Research Data
Design, Synthesis, and Pharmacological Evaluation of Novel Multisubstituted Pyridin-3-amine Derivatives as Multitargeted Protein Kinase Inhibitors for the Treatment of Non-Small Cell Lung Cancer
Source:
American Chemical Society (ACS)
Molecular Recognition of Protein Kinase Binding Pockets for Design of Potent and Selective Kinase Inhibitors
Source:
Wiley
A small molecule-kinase interaction map for clinical kinase inhibitors.
Source:
Springer Science and Business Media LLC
Aurora isoform selectivity: design and synthesis of imidazo[4,5-b]pyridine derivatives as highly selective inhibitors of Aurora-A kinase in cells.
Source:
American Chemical Society (ACS)
Structure-based design of 2,6,7-trisubstituted-7H-pyrrolo[2,3-d]pyrimidines as Aurora kinases inhibitors.
Source:
Elsevier BV
Relationships among Protein Conformation, Inhibitor Off-Rate, and Receptor Activity in Tumor Cells
Source:
American Association for Cancer Research (AACR)
ADP-Glo: A Bioluminescent and Homogeneous ADP Monitoring Assay for Kinases
Source:
Mary Ann Liebert Inc
Relationship of Aurora-A kinase and EGFR inhibition in non-small cell lung cancer (NSCLC) cell lines.
Source:
American Society of Clinical Oncology (ASCO)
Drugs to Treat Head and Neck Cancers: Mechanisms of Action
Source:
Springer Netherlands
The quest to overcome resistance to EGFR-targeted therapies in cancer
Source:
Springer Science and Business Media LLC
Synthetic Lethal Screen of an EGFR-Centered Network to Improve Targeted Therapies
Source:
American Association for the Advancement of Science (AAAS)
Aurora kinases in head and neck cancer
Source:
Elsevier BV
Design, synthesis and biological activity of N4-phenylsubstituted-7H-pyrrolo[2,3-d]pyrimidin-4-amines as dual inhibitors of aurora kinase A and epidermal growth factor receptor kinase
Source:
Taylor & Francis
Discovery of 1-{(3R,4R)-3-[({5-Chloro-2-[(1-methyl-1H-pyrazol-4-yl)amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl}oxy)methyl]-4-methoxypyrrolidin-1-yl}prop-2-en-1-one (PF-06459988), a Potent, WT Sparing, Irreversible Inhibitor of T790M-Containing EGFR Mutants
Source:
American Chemical Society (ACS)
Linking provided by
